Prot# C02-009: A Phase III, Randomized, Multicenter, Allopurinol and Placebo-Controlled Study Assessing the Safety and Efficacy of Oral Febuxostat in Subjects with Gout

Project: Research project

Project Details

StatusFinished
Effective start/end date4/5/04 → 3/1/05

Funding

  • TAP Pharmaceutical Products Inc. (C02-009)